Multivalent Calixarene-Based Liposomes as Platforms for Gene and Drug Delivery

• Published in: Pharmaceutics Vol. 13; no. 8; p. 1250
• Main Authors: Lebrón, José Antonio, López-López, Manuel, García-Calderón, Clara B., V. Rosado, Ivan, Balestra, Fernando R., Huertas, Pablo, Rodik, Roman V., Kalchenko, Vitaly I., Bernal, Eva, Moyá, María Luisa, López-Cornejo, Pilar, Ostos, Francisco J.
• Format: Journal Article
• Language: English
• Published: Basel MDPI AG 12.08.2021; MDPI
• Subjects: cationic calixarenes; doxorubicin; encapsulation; Hydration; Lipids; liposomes; nucleic acids; Spectrum analysis; transfection efficiency; United States > US; Germany
• ISSN: 1999-4923; 1999-4923
• DOI: 10.3390/pharmaceutics13081250

The formation of calixarene-based liposomes was investigated, and the characterization of these nanostructures was carried out using several techniques. Four amphiphilic calixarenes were used. The length of the hydrophobic chains attached to the lower rim as well as the nature of the polar group present in the upper rim of the calixarenes were varied. The lipid bilayer was formed with one calixarene and with the phospholipid 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine, DOPE. The cytotoxicity of the liposomes for various cell lines was also studied. From the results obtained, the liposomes formed with the least cytotoxic calixarene, (TEAC12)4, were used as nanocarriers of both nucleic acids and the antineoplastic drug doxorubicin, DOX. Results showed that (TEAC12)4/DOPE/p-EGFP-C1 lipoplexes, of a given composition, can transfect the genetic material, although the transfection efficiency substantially increases in the presence of an additional amount of DOPE as coadjuvant. On the other hand, the (TEAC12)4/DOPE liposomes present a high doxorubicin encapsulation efficiency, and a slow controlled release, which could diminish the side effects of the drug.